81_FR_7851 81 FR 7821 - Center for Scientific Review; Notice of Closed Meeting

81 FR 7821 - Center for Scientific Review; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 30 (February 16, 2016)

Page Range7821-7822
FR Document2016-02973

Federal Register, Volume 81 Issue 30 (Tuesday, February 16, 2016) 
[Federal Register Volume 81, Number 30 (Tuesday, February 16, 2016)]
[Notices]
[Pages 7821-7822]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-02973]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Special Topic: Social Sciences and Population Studies.
    Date: February 23, 2016.
    Time: 12:00 p.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Suzanne Ryan, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of

[[Page 7822]]

Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 
20892, (301) 435-1712, ryansj@csr.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: February 9, 2016.
Sylvia Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-02973 Filed 2-12-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 30 / Tuesday, February 16, 2016 / Notices 7821 Licensing Opportunity: Researchers at Title of invention: Modified griffithsin —A. Chatterjee et al.,Griffithsin and the NICHD seek licensing and/or co- tandemers for enhanced activity and Carrageenan Combination To Target development research collaborations for reduced viral aggregation. Herpes Simplex Virus 2 and Human Description of Technology: Griffithsin Papillomavirus, Antimicrob Agents the therapeutic management of Menkes Chemother. 2015 Dec; 59(12): 7290–7298. Disease and related copper transport (GRFT) is a lectin with potent antiviral disorders. properties that is capable of preventing Intellectual Property and treating infections caused by a HHS Reference No. E–034–2013/0– Contact Information number of enveloped viruses (including US–01. Requests for copies of the patent HIV, SARS, HCV, HSV, and Japanese PCT Application No. PCT/US2014/ application or inquiries about licensing, encephalitis) and is currently in clinical 040992 (HHS Reference No. E–034– research collaborations, and co- development as an anti-HIV 2013/0- US–01) filed June 5, 2013 development opportunities should be microbicide. In addition to its broad entitled ‘‘Modified griffithsin tandemers sent to John D. Hewes, Ph.D., email: antiviral activity, GRFT is stable at high for enhanced activity and reduced viral john.hewes@nih.gov. temperature and at a broad pH range, aggregation’’. Dated: February 8, 2016. displays low toxicity and Licensing and Collaborative/Co- John D. Hewes, immunogenicity, and is amenable to Development Research Opportunity: Technology Transfer Specialist, Technology large-scale manufacturing. Native GRFT Researchers at the NCI seek licensees Transfer Center, National Cancer Institute. is a domain-swapped homodimer that and/or co-development partners for the [FR Doc. 2016–02970 Filed 2–12–16; 8:45 am] binds to viral envelope glycoproteins commercialization of Griffithsin and BILLING CODE 4140–01–P and has displayed mid-picomolar Griffithsin tandemers, specifically, activity in cell-based anti-HIV assays. additional studies on stability, toxicity, This invention is directed to synthetic immunogenicity, and large-scale DEPARTMENT OF HEALTH AND proteins that comprise two (or more) production. HUMAN SERVICES obligate monomers (‘‘mGRFT’’) joined Dated: February 1, 2016. by an amino acid linker to form National Institutes of Health John D. Hewes, tandemers (‘‘mGRFT tandemers’’). Each Technology Transfer Specialist, Technology obligate monomer is generated by the Government-Owned Inventions; Transfer Center, National Cancer Institute. addition of Gly-Ser residues in the hinge Availability for Licensing region of wild-type GRFT. Two or more [FR Doc. 2016–02971 Filed 2–12–16; 8:45 am] BILLING CODE 4140–01–P AGENCY: National Institutes of Health, obligate monomers are joined by an HHS. amino acid linker to form the mGRFT ACTION: Notice. tandamers. The properties of the DEPARTMENT OF HEALTH AND mGRFT tandemers can be modulated by HUMAN SERVICES SUMMARY: The invention listed below is the length of the amino acid linker and owned by an agency of the U.S. the number of obligate monomers co- National Institutes of Health Government and is available for joined. mGRFT tandemers exhibit gore licensing and/or co-development in the potent anti-viral properties when Center for Scientific Review; Notice of U.S. in accordance with 35 U.S.C. 209 compared against native GRFT and are Closed Meeting and 37 CFR part 404 to achieve equipotent against viruses that are both expeditious commercialization of sensitive and resistant to naive GRFT. Pursuant to section 10(d) of the results of federally-funded research and As such, potential uses of the invention Federal Advisory Committee Act, as development. Foreign patent tandemers include topical and amended (5 U.S.C. App.), notice is applications are filed on selected intravenous therapy to treat HIV hereby given of the following meeting. inventions to extend market coverage The meeting will be closed to the infection, particularly to treat HIV for companies and may also be available public in accordance with the infections that are resistant to native for licensing and/or co-development. provisions set forth in sections GRFT. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., ADDRESSES: Information on licensing, Potential Commercial Applications as amended. The grant applications and co-development research collaborations, the discussions could disclose and/or copies of the U.S. patent • Broad-spectrum antiviral agent similar to wild type GRFT confidential trade secrets or commercial applications listed below may be property such as patentable material, obtained by contacting: Attn. Invention • Potential activity against SARS CoV, MERS, Ebola, HCV and influenza and personal information concerning Development and Marketing Unit, individuals associated with the grant Technology Transfer Center, National Value Proposition applications, the disclosure of which Cancer Institute, 9609 Medical Center • Broad antiviral activity would constitute a clearly unwarranted Drive, Mail Stop 9702, Rockville, MD, • Stable at high temperature and at a invasion of personal privacy. 20850–9702, Tel. 240–276–5515 or broad pH range email ncitechtransfer@mail.nih.gov. A Name of Committee: Center for Scientific • Displays low toxicity and Review Special Emphasis Panel; Special signed Confidential Disclosure immunogenicity. Topic: Social Sciences and Population Agreement may be required to receive Studies. copies of the patent applications. Development Stage: In vivo/Lead Date: February 23, 2016. FOR FURTHER INFORMATION CONTACT: Validation. mstockstill on DSK4VPTVN1PROD with NOTICES Time: 12:00 p.m. to 12:30 p.m. Inventor(s): Barry R. O’Keefe (NCI), A. Agenda: To review and evaluate grant Requests for copies of the patent Wlodawer (NCI), T. Moulaei (NCI). applications. application or inquiries about licensing and/or co-development should be sent Publication(s) Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 to John D. Hewes, Ph.D., email: —Moulaei T. et al., Griffithsin tandemers: (Telephone Conference Call). john.hewes@nih.gov. flexible and potent lectin inhibitors of the Contact Person: Suzanne Ryan, Ph.D., SUPPLEMENTARY INFORMATION: human immunodeficiency virus. Scientific Review Officer, Center for Technology description follows. Retrovirology. 2015 Jan 23;12:6. Scientific Review, National Institutes of VerDate Sep<11>2014 22:15 Feb 12, 2016 Jkt 238001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 E:\FR\FM\16FEN1.SGM 16FEN1

7822 Federal Register / Vol. 81, No. 30 / Tuesday, February 16, 2016 / Notices Health, 6701 Rockledge Drive, Room 3139, Background participants in NEXUS and certain MSC 7770, Bethesda, MD 20892, (301) 435– participants in SENTRI would still be 1712, ryansj@csr.nih.gov. Global Entry Program allowed to use the Global Entry kiosks. This notice is being published less than 15 In a notice published in the Federal Global Entry is a voluntary program days prior to the meeting due to the timing Register (78 FR 48706) on August 9, limitations imposed by the review and that allows for dedicated CBP processing of pre-approved travelers 2013, CBP expanded Global Entry funding cycle. arriving in the United States at Global eligibility to include citizens of the (Catalogue of Federal Domestic Assistance Republic of Korea who are participants Program Nos. 93.306, Comparative Medicine; Entry kiosks located at designated airports. On February 6, 2012, CBP in the Smart Entry System (SES), a 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, issued the final rule that promulgated trusted traveler program for pre- 93.846–93.878, 93.892, 93.893, National the regulation (8 CFR 235.12) to approved, low-risk travelers at Institutes of Health, HHS) establish Global Entry as an ongoing designated airports in the Republic of voluntary regulatory program in the Korea via the use of e-gates; a limited Dated: February 9, 2016. Federal Register (77 FR 5681). The final number of citizens of the State of Qatar; Sylvia Neal, rule contains a detailed description of and a limited number of citizens of the Program Analyst, Office of Federal Advisory United Kingdom who frequently travel Committee Policy. the program, the eligibility criteria, the application and selection process, and to the United States. [FR Doc. 2016–02973 Filed 2–12–16; 8:45 am] In a notice published in the Federal the initial airport locations. Travelers BILLING CODE 4140–01–P who wish to participate in Global Entry Register (80 FR 1509) on January 12, must apply via the Global On-Line 2015, CBP expanded Global Entry Enrollment System (GOES) Web site, eligibility to include citizens of the https://goes-app.cbp.dhs.gov, and pay Republic of Panama. Additionally, this DEPARTMENT OF HOMELAND the applicable fee. Applications for document announced that U.S. citizens SECURITY Global Entry must be completed and who participate in Global Entry or U.S. U.S. Customs and Border Protection submitted electronically. citizens who can utilize Global Entry kiosks as NEXUS or SENTRI Eligibility for participation in Global participants have the option to apply for [CBP Dec. No. 16–04] Entry is limited to U.S. citizens, U.S. membership in Panama Global Pass, the nationals, U.S. lawful permanent Republic of Panama’s trusted traveler Expansion of Global Entry Eligibility to residents, and certain nonimmigrant All Citizens of the Federal Republic of program. aliens from countries that have entered Germany into arrangements with CBP regarding Limited Global Entry Pilot for Certain AGENCY: U.S. Customs and Border international trusted traveler programs. German Citizens Protection; Department of Homeland Specifically, the regulation provides In the August 9, 2013 notice Security. that certain nonimmigrant aliens from referenced in the previous section, CBP ACTION: General notice. countries that have entered into also announced a limited Global Entry arrangements with CBP concerning pilot program allowing certain German SUMMARY: U.S. Customs and Border international trusted traveler programs citizens to apply for Global Entry. This Protection (CBP) has established the may be eligible to apply for pilot program allowed certain German Global Entry international trusted participation in Global Entry after CBP citizens who participated in ABG Plus, traveler program at most major U.S. announces the arrangement by Germany’s former trusted traveler airports. Global Entry allows pre- publication of a notice in the Federal program, to apply for participation in approved participants dedicated CBP Register. The notice will include the Global Entry.2 During this limited pilot, processing into the United States using country, the scope of eligibility of German citizens who were identified as Global Entry kiosks located at nonimmigrant aliens from that country potentially being eligible for designated airports. In 2013, CBP (e.g., whether only citizens of the participation in the pilot program announced a limited pilot program foreign country or citizens and non- received a promotional code and through which certain citizens of the citizens are eligible) and other information about the program from the Federal Republic of Germany (Germany) conditions that may apply based on the German government. The United States were eligible to apply for participation terms of the arrangement. See 8 CFR and Germany limited the number of in the Global Entry program. This 235.12(b)(1)(ii). In the preamble of the citizens who could apply for Global document announces that CBP is Global Entry final rule, CBP recognized Entry to allow for the development of concluding the pilot and expanding the existence of previous arrangements the program’s infrastructure. The notice eligibility in the Global Entry program it had with Mexico and the Netherlands stated that CBP expected to be able to to include all German citizens. regarding the international trusted expand eligiblility to include all Additionally, this document announces traveler programs and announced that German citizens in the near future and that certain U.S. citizens may apply for Mexican nationals and certain citizens that such an expansion would be membership in EasyPASS, Germany’s of the Netherlands were eligible to announced by notice in the Federal registered traveler program. apply for the Global Entry program. CBP Register and on http:// DATES: Global Entry eligibility will be further specified that Mexican nationals www.globalentry.gov. expanded to German citizens on and citizens of the Netherlands who mstockstill on DSK4VPTVN1PROD with NOTICES were existing participants in the Global Expansion of Global Entry Program to February 16, 2016. Applications will be Include All Citizens of Germany accepted beginning February 16, 2016. Entry pilot would be automatically enrolled in the ongoing Global Entry This document announces that FOR FURTHER INFORMATION CONTACT: program. CBP also stated that pursuant pursuant to the Joint Declaration signed Larry Panetta, Office of Field to a previous Federal Register notice,1 Operations, (202) 344–1253, notice, December 29, 2010 (75 FR 82202) for further Larry.A.Panetta@cbp.dhs.gov. 1 See the Utilization of Global Entry Kiosks by information. SUPPLEMENTARY INFORMATION: NEXUS and SENTRI Participants Federal Register 2 ABG Plus has since been discontinued. VerDate Sep<11>2014 22:15 Feb 12, 2016 Jkt 238001 PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 E:\FR\FM\16FEN1.SGM 16FEN1


Document Created: 2016-02-13 03:13:35
Document Modified: 2016-02-13 03:13:35
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesFebruary 23, 2016.
FR Citation81 FR 7821 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR